Max Chaffanet

8.4k total citations
105 papers, 4.4k citations indexed

About

Max Chaffanet is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Max Chaffanet has authored 105 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 33 papers in Oncology and 32 papers in Genetics. Recurrent topics in Max Chaffanet's work include Genomic variations and chromosomal abnormalities (22 papers), Cancer Genomics and Diagnostics (19 papers) and Acute Myeloid Leukemia Research (14 papers). Max Chaffanet is often cited by papers focused on Genomic variations and chromosomal abnormalities (22 papers), Cancer Genomics and Diagnostics (19 papers) and Acute Myeloid Leukemia Research (14 papers). Max Chaffanet collaborates with scholars based in France, United States and Belgium. Max Chaffanet's co-authors include Daniel Birnbaum, José Adélaı̈de, Pascal Finetti, François Bertucci, Patrice Viens, Emmanuelle Charafe‐Jauffret, Nathalie Cervera, Renaud Sabatier, Julien Mozziconacci and Arnaud Guillé and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Max Chaffanet

105 papers receiving 4.4k citations

Peers

Countries citing papers authored by Max Chaffanet

Since Specialization

Citations

This map shows the geographic impact of Max Chaffanet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Chaffanet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Chaffanet more than expected).

Fields of papers citing papers by Max Chaffanet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Chaffanet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Chaffanet. The network helps show where Max Chaffanet may publish in the future.

Co-authorship network of co-authors of Max Chaffanet

This figure shows the co-authorship network connecting the top 25 collaborators of Max Chaffanet. A scholar is included among the top collaborators of Max Chaffanet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Chaffanet. Max Chaffanet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing 2024 ·Briefings in Bioinformatics ·Arnaud Guillé, José Adélaı̈de, Pascal Finetti, Fabrice André, Daniel Birnbaum, Émilie Mamessier, François Bertucci, Max Chaffanet	2
2	ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines 2023 ·Pharmaceutics ·(unknown), José Adélaı̈de, Thi Khanh Le, (unknown), Pascal Finetti, Clément Paris, Arnaud Guillé, François Bertucci, Daniel Birnbaum, Palma Rocchi, Max Chaffanet	3
3	In skeletal muscle and neural crest cells, SMCHD1 regulates biological pathways relevant for Bosma syndrome and facioscapulohumeral dystrophy phenotype 2023 ·Nucleic Acids Research ·(unknown), (unknown), (unknown), Camille Dion, (unknown), David Hirst, Leslie Caron, Pierre Perrin, José Adélaı̈de, Max Chaffanet, Shifeng Xue, Karine Nguyen, Bruno Reversade, Jérôme Déjardin, Anaı̈s Baudot, Jérôme D. Robin, Frédérique Magdinier	3
4	BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib 2023 ·Frontiers in Oncology ·Carolina Velázquez, (unknown), (unknown), (unknown), Béatrice Orsetti, José Adélaı̈de, Arnaud Guillé, Simon Thézenas, Evelyne Lopez‐Crapez, Pierre‐Emmanuel Colombo, Max Chaffanet, Daniel Birnbaum, (unknown), William Jacot, Charles Theillet	5
5	TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT 2022 ·EMBO Molecular Medicine ·Alexandre de Nonneville, Sébastien Salas, François Bertucci, Alexander P. Sobinoff, José Adélaı̈de, Arnaud Guillé, Pascal Finetti, Jane R. Noble, (unknown), Max Chaffanet, (unknown), Hilda A. Pickett, Corinne Bouvier, Daniel Birnbaum, Roger R. Reddel, Vincent Géli	27
6	Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy 2022 ·Journal of Personalized Medicine ·(unknown), Arnaud Guillé, (unknown), Pierre‐Emmanuel Colombo, (unknown), José Adélaı̈de, Nadine Carbuccia, (unknown), Florence Boissière‐Michot, Evelyne Lopez‐Crapez, Michel Fabbro, Sébastien Gouy, Émilie Mamessier, Éric Lambaudie, Daniel Birnbaum, François Bertucci, Max Chaffanet	2
7	Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study 2022 ·Molecular Oncology ·Renaud Sabatier, Cécile Vicier, Séverine Garnier, Arnaud Guillé, Nadine Carbuccia, Nicolás Isambert, Florence Dalenc, Marie Robert, Christelle Lévy, Jihane Pakradouni, José Adélaı̈de, Max Chaffanet, (unknown), Émilie Mamessier, François Bertucci, Anthony Gonçalvès	5
8	Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate 2022 ·Molecular Cancer Therapeutics ·(unknown), (unknown), Emerence Crompot, (unknown), Pascal Finetti, (unknown), Arnaud Guillé, (unknown), (unknown), (unknown), Max Chaffanet, Anthony Gonçalvès, Emmanuelle Charafe‐Jauffret, Émilie Mamessier, Daniel Birnbaum, François Bertucci, Marc Lopez	39
9	NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers 2019 ·Molecular Oncology ·François Bertucci, (unknown), Pascal Finetti, Arnaud Guillé, José Adélaı̈de, Audrey Monneur, Nadine Carbuccia, Séverine Garnier, Piet Dirix, Anthony Gonçalvès, Peter Vermeulen, Bisrat G. Debeb, Xiaoping Wang, Luc Dirix, Naoto T. Ueno, Patrice Viens, Massimo Cristofanilli, Max Chaffanet, Daniel Birnbaum, Steven Van Laere	27
10	Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis 2010 ·Breast Cancer Research and Treatment ·Anthony Gonçalvès, Pascal Finetti, Renaud Sabatier, Marine Gilabert, José Adélaı̈de, Jean‐Paul Borg, Max Chaffanet, Patrice Viens, Daniel Birnbaum, François Bertucci	60
11	Sixteen–Kinase Gene Expression Identifies Luminal Breast Cancers with Poor Prognosis 2008 ·Cancer Research ·Pascal Finetti, Nathalie Cervera, Emmanuelle Charafe‐Jauffret, Christian Chabannon, Colette Charpin, Max Chaffanet, Jocelyne Jacquemier, Patrice Viens, Daniel Birnbaum, François Bertucci	96
12	Integrated Profiling of Basal and Luminal Breast Cancers 2007 ·Cancer Research ·José Adélaı̈de, Pascal Finetti, Ismahane Bekhouche, (unknown), Jeannine Geneix, Fabrice Sircoulomb, Emmanuelle Charafe‐Jauffret, Nathalie Cervera, Jérôme Desplans, Daniel Parzy, Eric Schoenmakers, Patrice Viens, J Jacquemier, Daniel Birnbaum, François Bertucci, Max Chaffanet	221
13	Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers 2006 ·Clinical Cancer Research ·Christophe Ginestier, Nathalie Cervera, Pascal Finetti, Séverine Esteyriès, Benjamin Esterni, José Adélaı̈de, Luc Xerri, Patrice Viens, Jocelyne Jacquemier, Emmanuelle Charafe‐Jauffret, Max Chaffanet, Daniel Birnbaum, François Bertucci	107
14	ETV6 gene rearrangements in invasive breast carcinoma 2005 ·Genes Chromosomes and Cancer ·A Letessier, Christophe Ginestier, Emmanuelle Charafe‐Jauffret, Nathalie Cervera, José Adélaı̈de, Véronique Gelsi‐Boyer, Jean‐Charles Ahomadegbe, Jean Bénard, Jocelyne Jacquemier, Daniel Birnbaum, Max Chaffanet	26
15	A Recurrent Chromosome Breakpoint in Breast Cancer at the *NRG1* / *Neuregulin 1* / *Heregulin* Gene 2004 ·Cancer Research ·(unknown), Suet‐Feung Chin, Christophe Ginestier, Valérie‐Jeanne Bardou, José Adélaı̈de, N. Gopalakrishna Iyer, María J. García, Jessica C. Pole, Grace Callagy, Stephen M. Hewitt, William J. Gullick, Jocelyne Jacquemier, Carlos Caldas, Max Chaffanet, Daniel Birnbaum, Paul A. Edwards	73
16	A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene 2003 ·Genes Chromosomes and Cancer ·José Adélaı̈de, (unknown), Anne Murati, Amber E. Alsop, Béatrice Orsetti, Julien Mozziconacci, Cornel Popovici, Christophe Ginestier, A Letessier, Céline Basset, Céline Courtay-Cahen, Jocelyne Jacquemier, Charles Theillet, Daniel Birnbaum, Paul A. Edwards, Max Chaffanet	44
17	Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer 2003 ·International Journal of Cancer ·Christophe Ginestier, Valérie‐Jeanne Bardou, Cornel Popovici, Emmanuelle Charafe‐Jauffret, François Bertucci, Jeannine Geneix, José Adélaı̈de, Max Chaffanet, J Hassoun, Patrice Viens, Jocelyne Jacquemier, Daniel Birnbaum	19
18	The 8p12 myeloproliferative disorder. t(8;19)(p12;q13.3): a novel translocation involving the FGFR1 gene . SHORT REPORT 2000 ·British Journal of Haematology ·Francine Mugneret, Max Chaffanet, Marc Maynadié, Géraldine Guasch, Bernardine Favre, Olivier Casasnovas, Daniel Birnbaum, Marie‐Josèphe Pébusque	24
19	Assignment of the Gene for the Human Proliferating Cell Nucleolar Protein P120 (NOL1) to Chromosome 12p13 by Fluorescence in Situ Hybridization and Polymerase Chain Reaction with Somatic Cell Hybrids 1994 ·Genomics ·Mathijs Baens, Max Chaffanet, Jeroen Aerssens, Jean‐Jacques Cassiman, Peter Marynen	4
20	Construction and Evaluation of a hncDNA Library of Human 12p Transcribed Sequences Derived from a Somatic Cell Hybrid 1993 ·Genomics ·(unknown), Max Chaffanet, Jean‐Jacques Cassiman, Herman Van den Berghe, Peter Marynen	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact